Role ofIFN-λs,IFN-λsrelated genes and theDEPDC5gene in Hepatitis B virus-related liver disease

Biology and significance of the JAK/STAT signalling pathways

(2012) Hiu Kiu et al.   GROWTH FACTORS

Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma

(2011) Jin Hou et al.   CANCER CELL

Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population

(2011) Qian Cui et al.   INFECTION GENETICS AND EVOLUTION

Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population

(2011) Wanyu Li et al.   LIVER INTERNATIONAL

Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers

(2011) Daiki Miki et al.   NATURE GENETICS

Cell-Permeable Peptide DEPDC1-ZNF224 Interferes with Transcriptional Repression and Oncogenicity in Bladder Cancer Cells

(2010) Y. Harada et al.   CANCER RESEARCH

Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

(2010) Andri Rauch et al.   GASTROENTEROLOGY

Association Between Hepatitis B Viral Burden in Chronic Infection and a Functional Single Nucleotide Polymorphism of the PDCD1 Gene

(2010) Linghua Zheng et al.   JOURNAL OF CLINICAL IMMUNOLOGY

IL28B inhibits hepatitis C virus replication through the JAK–STAT pathway

(2010) Leiliang Zhang et al.   JOURNAL OF HEPATOLOGY

IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC

(2010) Carlo Fabris et al.   JOURNAL OF HEPATOLOGY

IL28BPolymorphism Does Not Determine Outcomes of Hepatitis B Virus or HIV Infection

(2010) Maureen P. Martin et al.   JOURNAL OF INFECTIOUS DISEASES

Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities

(2010) Nicole E. Pagliaccetti et al.   VIROLOGY

Type III IFNs: New layers of complexity in innate antiviral immunity

(2009) Nina Ank et al.   BIOFACTORS

Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity

(2009) M. P. Morrow et al.   BLOOD

Association study of IFNAR2 and IL10RB genes with the susceptibility and interferon response in HBV infection

(2009) Q.-M. Gong et al.   JOURNAL OF VIRAL HEPATITIS

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

(2009) David L. Thomas et al.   NATURE

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

(2009) Vijayaprakash Suppiah et al.   NATURE GENETICS

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS

Diagnosis and Treatment of Hepatocellular Carcinoma

(2008) Hashem B. El-Serag et al.   GASTROENTEROLOGY

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma

(2008) Shunsuke Ura et al.   HEPATOLOGY

Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome

(2008) Ann L. Truelove et al.   International Journal of Immunogenetics